May 16, 2018 Lab Top-10 Life Science Tools M&A, Partnerships

MilliporeSigma to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children

News Release May 16, 2018 Your Contact: Karen Tiano +1 978 495 0093 Collaboration with Washington University on gut bacteria research could lead to diagnostics, treatment for malnourished children Study to use MilliporeSigma’s genome-editing technology Burlington, Massachusetts, May 16, 2018 — MilliporeSigma, a leader in genome editing, today announced a collaboration with Washington University in St.... Read more

May 14, 2018 Clinical Research/Diagn. Life Science Tools PR/Corporate

Precipio Announces Preliminary Q1 2018 Year-Over-Year Revenue Increase of 286%

Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW HAVEN, Conn., May 14, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces preliminary, unaudited 1st quarter 2018 revenues of approximately $712,000, representing a 286% increase from the same quarter in the prior year. Drivers of revenue growth that have been... Read more

May 8, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools PR/Corporate

Luna DNA Raises $4 Million Including Key Investors Illumina Ventures and Arch Venture Partners

Funding supports company’s mission to launch a medical discovery platform and engage a global community of data contributors   SAN DIEGO, May 8, 2018 /PRNewswire/ — Luna DNA, the first community-owned genomic and medical research database, today announced financing from key investors Illumina Ventures and Arch Venture Partners. Additional investors include UK-based Bridgelink Capital; Seattle-based Hemisphere Ventures; and Dr. Aristides Patrinos, a former leader... Read more

May 8, 2018 Licensing, IP, and Legal Life Science Tools

Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore

MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement litigation between the parties in the United Kingdom and Germany, under which Oxford Nanopore... Read more

May 8, 2018 Licensing, IP, and Legal Life Science Tools

Oxford Nanopore announces favourable outcome in UK and German patent litigation against Pacific Biosciences

Wed 9th May 2018 Oxford Nanopore and Pacific Biosciences have agreed to discontinue UK and German litigation. In the settlement, Oxford Nanopore agreed not to sell its 2D kits in UK and Germany. 2D is, in any case, obsolete and was globally discontinued in May 2017, when Oxford Nanopore replaced it with the superior 1D^2... Read more

May 8, 2018 Life Science Tools PR/Corporate

Horizon Discovery appoints Terry Pizzie as Chief Executive Officer

Location: Cambridge, UK 08/05/2018 Cambridge, UK, 8 May 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Group” or “the Company”), a global leader in gene editing and gene modulation technologies, is pleased to announce the appointment of Terry Pizzie as Chief Executive Officer and Board Director with immediate effect. Terry joined Horizon Discovery in 2017... Read more

May 4, 2018 Lab Top-10 Life Science Tools

Agilent Expands Logistics Center in Texas

Agilent Expands Logistics Center in Texas Construction Anticipates Future Growth in Genomics Market SANTA CLARA, Calif., May 4, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it is breaking ground on a 15,000-square-foot expansion of the company’s logistics center in Cedar Creek, Texas. The expansion will increase Agilent’s capacity to house inventory to fulfill... Read more

May 2, 2018 Lab Top-10 Life Science Tools PR/Corporate

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast. Bank of America Merrill Lynch Health Care Conference in Las Vegas, NVWednesday, May 16, 2018 at 3:40 pm Pacific Time The live webcast can be accessed in the Investor Relations... Read more

April 26, 2018 Cell Analysis Tools Informatics & Software Life Science Tools PR/Corporate

10x Genomics Completes $50 Million Series D Financing and $75M Debt Facility

PLEASANTON, CA.—April 26, 2018—10x Genomics, a company focused on accelerating genomic discovery, today announced that it had raised $125 million in funding. The funding included a $50 million Series D financing. It was led by Meritech Capital Partners and included new investor Wells Fargo Strategic Capital along with current investors Paladin Capital, Fidelity and the... Read more